DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
CD3/CD19 negative hematopoietic stem cells
( DrugBank: - / KEGG DRUG: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
85
特発性間質性肺炎
1
85. 特発性間質性肺炎
臨床試験数
:
627
/
薬物数
:
443
- (
DrugBank
:
120
) /
標的遺伝子数
:
99
-
標的パスウェイ数
:
212
10
50
100
ALL
trials per page:
Showing 1 to 1 of 1 trials
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT03500731
(
ClinicalTrials.gov
)
April 19, 2018
20180419
30/3/2018
20180330
Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
Lung Transplant in Tandem With Bone Marrow Transplant for Combined Lung and Bone Marrow Failure
Idiopathic Pulmonary Fibrosis;Emphysema or COPD
Biological:
CD3/CD19
negative
hematopoietic
stem
cells
;Drug: Rituximab;Drug: Alemtuzumab;Drug: Fludarabine;Drug: Thiotepa;Drug: G-CSF;Drug: Hydroxyurea
Biological:
CD3/CD19
negative
hematopoietic
stem
cells
;Drug: Rituximab;Drug: Alemtuzumab;Drug: Fluda ...
Paul Szabolcs
NULL
Recruiting
18 Years
60 Years
All
8
Phase 1/Phase 2
United States